REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886F907. A total of 10 filers reported holding REGENERON PHARMACEUTICALS in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,252,424 | -70.9% | 31,900 | -74.6% | 0.09% | -69.7% |
| Q2 2023 | $90,248,624 | -7.2% | 125,600 | +6.1% | 0.29% | -17.4% |
| Q1 2023 | $97,285,728 | +68.3% | 118,400 | +47.8% | 0.35% | +161.9% |
| Q4 2022 | $57,791,349 | +31.5% | 80,100 | +25.5% | 0.13% | +55.8% |
| Q3 2022 | $43,950,000 | +31.6% | 63,800 | +12.9% | 0.09% | +65.4% |
| Q2 2022 | $33,399,000 | -16.1% | 56,500 | -0.9% | 0.05% | +33.3% |
| Q1 2022 | $39,810,000 | -52.0% | 57,000 | -56.6% | 0.04% | -41.8% |
| Q4 2021 | $82,855,000 | +4.2% | 131,200 | -0.2% | 0.07% | -22.1% |
| Q3 2021 | $79,521,000 | +31.6% | 131,400 | +21.4% | 0.09% | +17.8% |
| Q2 2021 | $60,434,000 | +25.5% | 108,200 | +6.3% | 0.07% | +2.8% |
| Q1 2021 | $48,166,000 | +15.3% | 101,800 | +17.7% | 0.07% | -1.4% |
| Q4 2020 | $41,789,000 | +661.7% | 86,500 | +782.7% | 0.07% | +323.5% |
| Q3 2020 | $5,486,000 | -24.8% | 9,800 | -16.2% | 0.02% | -50.0% |
| Q2 2020 | $7,297,000 | +293.2% | 11,700 | +207.9% | 0.03% | +126.7% |
| Q1 2020 | $1,856,000 | – | 3,800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 56,500 | $33,399,000 | 0.05% |
| JANE STREET GROUP, LLC | 100,400 | $59,349,000 | 0.02% |
| SIMPLEX TRADING, LLC | 12,000 | $7,093,000 | 0.01% |
| JPMORGAN CHASE & CO | 500 | $296,000 | 0.00% |
| Allianz Asset Management GmbH | 600 | $355,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |